IV obesity and atrial fibrillation or flutter, achieving a 92.3% success rate without any airway events, a study finds.

Our heartbeat serves as a vital indicator, which shows how well our heart functions. The heart experiences irregular rhythms ...

A Food and Drug Administration (FDA) advisory committee has voted 11 to 2 against a recommendation that the agency approve a long-studied antiarrhythmic agent for cardioversion of recent-onset atrial ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...

Introduction: There is insufficient evidence on the efficacy and safety of pharmacological cardioversion of recent-onset atrial fibrillation (AF) in elderly patients. Antazoline has been shown to be ...

Please provide your email address to receive an email when new articles are posted on . New-onset atrial fibrillation and atrial flutter are as common in hospitalized patients with influenza as with ...

Catheter-based pulmonary vein isolation is an effective treatment for paroxysmal atrial fibrillation. Pulsed field ablation, which delivers microsecond high-voltage electrical fields, may limit damage ...

VIENNA--(BUSINESS WIRE)--AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug Administration (FDA) has granted regulatory approval for Rapiblyk ...